- Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analystsMark Jit
Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
BMC Med 11:23. 2013..This report describes the consensus of an expert group convened by the World Health Organization, prioritizing key issues to be addressed when considering economic analyses to support HPV vaccine introduction in these countries...
- A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing ToolRaymond Hutubessy
Immunization, Vaccines and Biologicals IVB Department, World Health Organization WHO, 20 Avenue Appia, 1211, Geneva 27, Switzerland
BMC Med 10:136. 2012..Tanzania is presented as a case study where the WHO C4P tool was used to cost and plan the roll-out of HPV vaccines nationwide as part of the national comprehensive cervical cancer prevention and control strategy...
- A global health partnership's use of time-limited support to catalyze health practice change: the case of GAVI's Injection Safety SupportAnn Levin
PLoS ONE 5:e12986. 2010....
- Role of the private sector in the provision of immunization services in low- and middle-income countriesAnn Levin
Independent Consultant, 6414 Hollins Dr, Bethesda, MD 20817, USA
Health Policy Plan 26:i4-12. 2011..The review revealed many geographical and thematic gaps in the literature on the role and regulation of the private sector in the delivery of immunization services in low- and middle-income countries...